New Study Finds Keytruda Combo Falls Short of Expectations in Unresectable-Non-Metastatic Hepatocellular Carcinoma

There may be several reasons that HCC cancer of the liver cannot be removed. It may be due to the size of the tumor, or location proximity to major blood…

Continue Reading New Study Finds Keytruda Combo Falls Short of Expectations in Unresectable-Non-Metastatic Hepatocellular Carcinoma

Breaking the “Undruggable” Barrier: FOG-001 Earns FDA Fast Track for Rare Soft-Tissue Cancer

Parabilis Medicines has achieved a significant milestone in cancer drug development, receiving FDA Fast Track designation for FOG-001, a groundbreaking first-in-class therapy targeting desmoid tumors. As reported by Drugs.com, this…

Continue Reading Breaking the “Undruggable” Barrier: FOG-001 Earns FDA Fast Track for Rare Soft-Tissue Cancer